United States · Platforms & data · The Motley Fool

Twist Bioscience: 3 Key Takeaways for Long-Term Investors

Published by The Motley Fool · United States 1 h ago

Detailed summary

Twist is expanding from 10 to 16 DNA writers while reinvesting its new profits, a plan that matters for anyone weighing growth against cash generation.

Read the full article on The Motley Fool Sign in to save

MarketNews shows the headline and summary published by the outlet. The full article is on the publisher's website. (www.fool.com)

Also worth reading

Seeking Alpha

Peraso appoints Kevin Liu as interim CFO

MarketWatch

The S&P 500 is shrugging off Nvidia’s selloff this week. Here’s what’s keeping the rest of the market afloat.

Investing.com

SpaceX, Tesla merger talks progress, Bloomberg News reports

CNBC

In a policy switch, the Fed says its October 2027 meeting will not see a vote on interest rates

Benzinga

Toncoin (TON) Price Prediction 2025, 2026, 2027-2030

Stocktwits